2012 | Stephen G. Landt, Georgi K. Marinov, Anshul Kundaje, Pouya Kheradpour, Florencia Pauli, Serafim Batzoglou, Bradley E. Bernstein, Peter Bickel, James B. Brown, Philip Cayting, Yiwen Chen, Gilberto DeSalvo, Charles Epstein, Katherine I. Fisher-Aylor, Gha Euskirchen, Mark Gerstein, Jason Gertz, Alexander J. Hartemink, Michael M. Hoffman, Vishwanath R. Iyer, Youngsook L. Jung, Subhradip Karmakar, Manolis Kellis, Peter V. Kharchenko, Qunhua Li, Tao Liu, X. Shirley Liu, Lijia Ma, Aleksandar Milosavljevic, Richard M. Myers, Peter J. Park, Michael J. Pazin, Marc D. Perry, Debasish Raha, Timothy E. Reddy, Joel Rozowsky, Noam Shores, Arend Sidow, Matthew Slattery, John A. Stamatoyannopoulos, Michael Y. Tolstorukov, Kevin P. White, Simon Xi, Peggy J. Farnham, Jason D. Lieb, Barbara J. Wold, and Michael Snyder
The ENCODE and modENCODE consortia have developed a set of guidelines and practices for ChIP-seq experiments to ensure consistent and high-quality data. These guidelines cover antibody validation, experimental replication, sequencing depth, data reporting, and quality assessment. The consortium emphasizes the importance of antibody specificity and sensitivity, with detailed protocols for characterizing antibodies against transcription factors and histone modifications. They recommend using multiple validation methods, including immunoblot analysis, immunofluorescence, knockdown experiments, mass spectrometry, and motif enrichment. For histone modifications, specific tests such as peptide binding assays and mutants defective in histone modification enzymes are used. The consortium also provides recommendations for sequencing depth, library complexity, and control sample preparation to ensure reproducibility and accurate site discovery. These guidelines aim to maximize the utility and reliability of ChIP-seq data for various biological studies.The ENCODE and modENCODE consortia have developed a set of guidelines and practices for ChIP-seq experiments to ensure consistent and high-quality data. These guidelines cover antibody validation, experimental replication, sequencing depth, data reporting, and quality assessment. The consortium emphasizes the importance of antibody specificity and sensitivity, with detailed protocols for characterizing antibodies against transcription factors and histone modifications. They recommend using multiple validation methods, including immunoblot analysis, immunofluorescence, knockdown experiments, mass spectrometry, and motif enrichment. For histone modifications, specific tests such as peptide binding assays and mutants defective in histone modification enzymes are used. The consortium also provides recommendations for sequencing depth, library complexity, and control sample preparation to ensure reproducibility and accurate site discovery. These guidelines aim to maximize the utility and reliability of ChIP-seq data for various biological studies.